Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

New survey reveals Canadians are largely unaware about osteoporosis and the serious consequences it can have on their health TORONTO, ON (February 2, 2016) – Snow and ice can make walking […]

Facts & Stats Learn more about osteoporosis and related fractures Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which can lead to increased risk […]

OSTEOPOROSIS AND OSTEOARTHRITIS The prefix “osteo” (which means “bone”) is the only thing that osteoporosis and osteoarthritis have in common. Despite the fact that osteoporosis, arthritis and osteoarthritis (a form […]

Advocate Educate, empower and support In keeping with our mission to educate, empower and support individuals and communities in the prevention and treatment of osteoporosis, Osteoporosis Canada communicates concerns about various […]

A recent report by the US Preventive Services Task Force (USPSTF) suggests that low doses of vitamin D up to 400 IU daily and calcium supplements up to 1000 mg […]

Osteoporosis Canada’s overall position statement in response to this study: This study did not specifically address the vitamin D requirements of individuals with osteoporosis, those with risk factors for osteoporotic […]

MEET THE CMC FACULTY Dr. Cathy Craven University of Toronto  Toronto, ON Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor […]

It is possible to travel safely and enjoyably with osteoporosis, but there are precautions that need to be taken, as well as those related to the pandemic. More tips and […]